{"id":"https://openalex.org/W2803073301","doi":"https://doi.org/10.1016/j.jid.2018.03.395","title":"388 A phase Ib trial in AD patients evaluating safety, tolerability, pharmacokinetics and efficacy of topical formulations containing the kappa-opioid receptor agonist WOL071-007","display_name":"388 A phase Ib trial in AD patients evaluating safety, tolerability, pharmacokinetics and efficacy of topical formulations containing the kappa-opioid receptor agonist WOL071-007","publication_year":2018,"publication_date":"2018-04-19","ids":{"openalex":"https://openalex.org/W2803073301","doi":"https://doi.org/10.1016/j.jid.2018.03.395","mag":"2803073301"},"language":"en","primary_location":{"id":"doi:10.1016/j.jid.2018.03.395","doi":"https://doi.org/10.1016/j.jid.2018.03.395","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jid.2018.03.395","pdf_url":"https://www.jidonline.org/article/S0022-202X(18)30621-3/pdf","source":{"id":"https://openalex.org/S28607811","display_name":"Journal of Investigative Dermatology","issn_l":"0022-202X","issn":["0022-202X","1523-1747"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Investigative Dermatology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jidonline.org/article/S0022-202X(18)30621-3/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058633327","display_name":"Michael Soeberdt","orcid":"https://orcid.org/0000-0003-2594-9901","observed_orcids":["https://orcid.org/0000-0003-2594-9901"]},"institutions":[{"id":"https://openalex.org/I4210086764","display_name":"Dr. August Wolff (Germany)","ror":"https://ror.org/000m3hy37","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210086764"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M. Soeberdt","raw_affiliation_strings":["Dr. August Wolff, Bielefeld, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. August Wolff, Bielefeld, Germany","institution_ids":["https://openalex.org/I4210086764"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006330750","display_name":"Clarissa Masur","orcid":"https://orcid.org/0000-0001-7361-727X","observed_orcids":["https://orcid.org/0000-0001-7361-727X"]},"institutions":[{"id":"https://openalex.org/I4210086764","display_name":"Dr. August Wolff (Germany)","ror":"https://ror.org/000m3hy37","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210086764"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"C. Masur","raw_affiliation_strings":["Dr. August Wolff, Bielefeld, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. August Wolff, Bielefeld, Germany","institution_ids":["https://openalex.org/I4210086764"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013120423","display_name":"Ulrich Knie","orcid":"https://orcid.org/0000-0001-7142-0377","observed_orcids":["https://orcid.org/0000-0001-7142-0377"]},"institutions":[{"id":"https://openalex.org/I4210086764","display_name":"Dr. August Wolff (Germany)","ror":"https://ror.org/000m3hy37","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210086764"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"U. Knie","raw_affiliation_strings":["Dr. August Wolff, Bielefeld, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. August Wolff, Bielefeld, Germany","institution_ids":["https://openalex.org/I4210086764"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112434001","display_name":"Dieter Metze","orcid":"https://orcid.org/0000-0002-8058-6683","observed_orcids":["https://orcid.org/0000-0002-8058-6683"]},"institutions":[{"id":"https://openalex.org/I4210103666","display_name":"University Hospital M\u00fcnster","ror":"https://ror.org/01856cw59","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210103666"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"D. Metze","raw_affiliation_strings":["University Hospital Muenster, Muenster, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Muenster, Muenster, Germany","institution_ids":["https://openalex.org/I4210103666"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002640669","display_name":"Christoph Abels","orcid":"https://orcid.org/0000-0002-7778-7740","observed_orcids":["https://orcid.org/0000-0002-7778-7740"]},"institutions":[{"id":"https://openalex.org/I4210086764","display_name":"Dr. August Wolff (Germany)","ror":"https://ror.org/000m3hy37","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210086764"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"C. Abels","raw_affiliation_strings":["Dr. August Wolff, Bielefeld, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. August Wolff, Bielefeld, Germany","institution_ids":["https://openalex.org/I4210086764"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":null,"fwci":0.5273,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.65962823,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":95},"biblio":{"volume":"138","issue":"5","first_page":"S66","last_page":"S66"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.010200000368058681,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kappa-opioid-receptor-agonists","display_name":"kappa opioid receptor agonists","score":0.9860000014305115},{"id":"https://openalex.org/keywords/atopic-dermatitis","display_name":"atopic dermatitis","score":0.9710000157356262},{"id":"https://openalex.org/keywords/topical-preparations","display_name":"topical formulation","score":0.8989999890327454},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7919999957084656},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.9300000071525574},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.7630000114440918},{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.8610000014305115},{"id":"https://openalex.org/keywords/skin-inflammation","display_name":"skin inflammation","score":0.7990000247955322}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.9360522031784058},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7314974665641785},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.727874755859375},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6073236465454102},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5873498916625977},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5588316321372986},{"id":"https://openalex.org/C2778329239","wikidata":"https://www.wikidata.org/wiki/Q268667","display_name":"Atopic dermatitis","level":2,"score":0.5029625296592712},{"id":"https://openalex.org/C2780501606","wikidata":"https://www.wikidata.org/wiki/Q7389221","display_name":"SCORAD","level":4,"score":0.4605869650840759},{"id":"https://openalex.org/C184389661","wikidata":"https://www.wikidata.org/wiki/Q14897645","display_name":"\u03ba-opioid receptor","level":4,"score":0.4212755858898163},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.39762887358665466},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35584551095962524},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.34570449590682983},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.27670350670814514},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.20441260933876038},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.10096389055252075},{"id":"https://openalex.org/C2776173921","wikidata":"https://www.wikidata.org/wiki/Q25326609","display_name":"Dermatology Life Quality Index","level":3,"score":0.06764864921569824},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jid.2018.03.395","doi":"https://doi.org/10.1016/j.jid.2018.03.395","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jid.2018.03.395","pdf_url":"https://www.jidonline.org/article/S0022-202X(18)30621-3/pdf","source":{"id":"https://openalex.org/S28607811","display_name":"Journal of Investigative Dermatology","issn_l":"0022-202X","issn":["0022-202X","1523-1747"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Investigative Dermatology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jid.2018.03.395","doi":"https://doi.org/10.1016/j.jid.2018.03.395","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jid.2018.03.395","pdf_url":"https://www.jidonline.org/article/S0022-202X(18)30621-3/pdf","source":{"id":"https://openalex.org/S28607811","display_name":"Journal of Investigative Dermatology","issn_l":"0022-202X","issn":["0022-202X","1523-1747"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Investigative Dermatology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309567","display_name":"Therakos","ror":"https://ror.org/01akman82"},{"id":"https://openalex.org/F4320315076","display_name":"Mallinckrodt Pharmaceuticals","ror":null}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2803073301.pdf","grobid_xml":"https://content.openalex.org/works/W2803073301.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7026562812","https://openalex.org/W4389100739","https://openalex.org/W4285984854","https://openalex.org/W4413295990","https://openalex.org/W4416087724","https://openalex.org/W2938616818","https://openalex.org/W4256243785","https://openalex.org/W2343091979","https://openalex.org/W3033658695","https://openalex.org/W2117159275"],"abstract_inverted_index":null,"counts_by_year":[{"year":2020,"cited_by_count":2}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2018-05-17T00:00:00"}